Phase Forward buys into next-generation IRT with Clarix acquisition
US-Based Phase Forward, specialized in data management solutions for clinical trials and drug safety pays US$40 millions for Clarix LLC, a provider of fully Web-integrated interactive response technology (IRT). Read more
No commentsClinPhone acquired !?
And the winner is … PAREXEL !
A couple of weeks ago we learned that Parexel has made an offer of $182 million to acquire ClinPhone, providing software to ease patient recruitment and manage clinical trial data.
Once Parexel made the offer back in June, Quintiles also got interested in the acquisition.
However Quintiles now steps back from the table and they will most likely develop in-house technology to reduce costs of trials.
It looks like Parexel can now complete the acquisition !
No comments
Who will acquire ClinPhone…?
ClinPhone, the world’s leading Clinical Technology Organization, will be acquired within the next couple of months.
CRO Parexel already made a $182 million bid, however Quintiles is discussing the acquisition azs well, and if they agree it will most likely be more than what Parexel offers.
No comments
